Influence of age and HLA type on interferon-gamma (IFN-γ) responses to a naturally occurring polymorphic epitope of Plasmodium falciparum liver stage antigen-1 (LSA-1)

Clinical and Experimental Immunology

Volumn 122, Issue 1, 2000, Pages 94-100

  Bucci, K ^a   Kastens, W ^a   Hollingdale, M R ^a,b   Shankar, A ^a,d   Alpers, M P ^a,c   King, C L ^a   Kazura, J W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cytokine; HLA; LSA 1; Malaria; Polymorphism

Indexed keywords

CYTOKINE; DNA; EPITOPE; ERYTHROCYTE ANTIGEN; GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; LIVER STAGE ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; GENETIC POLYMORPHISM; GENOTYPE; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOGENICITY; LIVER DISEASE; MALARIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGING; ALLELES; ANIMALS; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-A2 ANTIGEN; HLA-B ANTIGENS; HUMANS; INTERFERON TYPE II; MALARIA, FALCIPARUM; MIDDLE AGED; PAPUA NEW GUINEA; PEPTIDES; PLASMODIUM FALCIPARUM;

EID: 0033775528     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01346.x     Document Type: Article

References (35)

1. Malaria vaccines: Multiple targets
2. Circumventing genetic restriction of protection against malaria with multigene DNA immunizations: CD8+ T cell-, IFN-γ-, and nitric oxide-dependent immunity
3. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria
4. Human lymphocyte proliferative response to sporozoite T cell epitopes correlates with resistance to falciparum malaria
5. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein
6. Lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver- and blood-stage malaria antigens
7. Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy
8. Human T cell recognition of the circumsporozoite protein of Plasmodium falciparum-immunodominant T cell domains map to the polymorphic regions of the molecule
9. Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults
10. Association of malaria parasite population structure, HLA, and immunological antagonism
11. A liver stage-specific antigen of Plasmodium falciparum characterized by gene cloning
12. Plasmodium falciparum liver stage antigen-I is well conserved and contains potent B and T cell determinants
13. Parasite antigen-specific interleukin-10 and antibody responses predict accelerated parasite clearance in Plasmodium falciparum malaria
14. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children
15. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum
16. T cell immunity to peptide epitopes of Liver Stage Antigen 1 in a malaria holoendemic area of Papua New Guinea
17. The epidemiology of malaria in the Wosera area, Papua New Guinea, in prearation for vaccine trials. I. Malariametric indices and immunity
18. The epidemiology of malaria in the Wosera area, Papua New Guinea, in preparation for vaccine trials, II, Mortality and morbidity
19. Serologic and genetic characterization of Plasmodium vivax from whole blood-impregnated filter paper discs
20. Sequence analysis of serological HLA-A11 split antigens, A11.1 and A11.2
21. General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interactions at the level of individual amino acids
22. Structure of peptides associated with class I and II MHC molecules
23. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin
24. Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant .174xCEM.T2
25. Helminth- and Bacillus Calmette Guerin-induced immunity in children sensitized in utero to filariasis and schistosomiasis
26. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
27. Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein of Plasmodium falciparum in West Africans
28. Genetic analysis of host-parasite coevolution in human malaria
29. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum
30. Sequence variations in the non-repetitive regions of liver stage-specific antigen-1
31. Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax
32. Immune effector mechanisms in malaria
33. Rapid effector function in CD8+ memory T cells
34. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules
35. HLA-peptide tetrameric complexes